Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of glycemic control with insulin alone versus insulin plus sulfonylurea in type 2 diabetes
IRCT201204229536N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Glycemic control. Started Mar 2012; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201204229536N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204229536N1.